PMID- 7525552 OWN - NLM STAT- MEDLINE DCOM- 19941129 LR - 20210212 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 269 IP - 44 DP - 1994 Nov 4 TI - c phosphorylation and activation of the IGF-I receptor in src-transformed cells. PG - 27315-21 AB - Using a panel of src mutants partially defective for malignant transformation, our laboratory has previously identified the insulin-like growth factor (IGF-I) receptor as a protein whose tyrosine phosphorylation correlates with transformation by src in embryonic chick cells (Kozma et al., 1990; Kozma and Weber, 1990). It has not been clear, however, whether src-induced phosphorylation altered the enzymatic or signaling properties of the IGF-I receptor and thus whether the IGF-I receptor could be a functionally significant target for pp60v-src. To examine the effect of src expression on the activity of the IGF-I receptor, the human IGF-I receptor was expressed in Rat-1 fibroblasts co-expressing the temperature-sensitive v-src mutant, tsLA29. The IGF-I receptor exhibited an elevated level of tyrosine phosphorylation in src transformed cells even in the absence of IGF-I treatment. Increased receptor phosphorylation occurred rapidly when cells expressing a temperature-conditional src mutant were shifted from the restrictive to the permissive temperature. Src-induced phosphorylation of the receptor was correlated with an increase in the in vitro tyrosine kinase activity of the receptor, both toward itself and exogenous substrates. The src-induced increase in receptor activity was shown to be dependent on tyrosine phosphorylation, as treatment with a tyrosine-specific phosphatase lowered receptor activity. A kinase-defective mutant of the IGF-I receptor also became constitutively phosphorylated in src-transformed cells, ruling out a possible autocrine mechanism for this phosphorylation. Collectively these data indicate that pp60v-src induces ligand-independent phosphorylation and activation of the IGF-I receptor by an intracellular mechanism, consistent with the possibility that receptor phosphorylation could contribute to the genesis of the transformed phenotype. FAU - Peterson, J E AU - Peterson JE AD - Department of Microbiology, University of Virginia, Charlottesville 22908. FAU - Jelinek, T AU - Jelinek T FAU - Kaleko, M AU - Kaleko M FAU - Siddle, K AU - Siddle K FAU - Weber, M J AU - Weber MJ LA - eng GR - CA 39076/CA/NCI NIH HHS/United States GR - CA 40042/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 21820-51-9 (Phosphotyrosine) RN - 42HK56048U (Tyrosine) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 2.7.10.1 (Receptor, IGF Type 1) RN - EC 2.7.10.2 (Oncogene Protein pp60(v-src)) SB - IM GS - src MH - Animals MH - Cell Line MH - *Cell Transformation, Viral MH - *Genes, src MH - Humans MH - Oncogene Protein pp60(v-src)/*metabolism MH - Phosphorylation MH - Phosphotyrosine MH - Rats MH - Receptor Protein-Tyrosine Kinases/metabolism MH - Receptor, IGF Type 1/*metabolism MH - Time Factors MH - Transfection MH - Tyrosine/analogs & derivatives/metabolism EDAT- 1994/11/04 00:00 MHDA- 1994/11/04 00:01 CRDT- 1994/11/04 00:00 PHST- 1994/11/04 00:00 [pubmed] PHST- 1994/11/04 00:01 [medline] PHST- 1994/11/04 00:00 [entrez] AID - S0021-9258(18)46987-6 [pii] PST - ppublish SO - J Biol Chem. 1994 Nov 4;269(44):27315-21.